Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Passive Infrasound-to-ultrasound Vibrome Biosignatures of Lung Development in Newborn Infants

NCT05827250 is registered in ClinicalTrials.gov with Level 42 AI, Inc. as lead sponsor.

NCT NCT05827250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05827250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Passive Infrasound-to-ultrasound Vibrome Biosignatures of Lung Development in Newborn Infants
Lead sponsor
Level 42 AI, Inc.
Phase
Observational
Overall status
Unknown status
Start date
February 13, 2023
Completion date
February 28, 2025
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

premature birth, premature lungs, prematurity, prematurity; extreme